AVR (Anteris Technologies Global) Days Payable: 5,956.86 (As of Mar. 2026) — 2066% Above Median


AVR Anteris Technologies Global Corp AVR
23 GF Score
Price $9.87
! 7 Warning Signs
View Full Analysis

What is Anteris Technologies Global Days Payable?

Anteris Technologies Global AVR -5.00% 23 Days Payable is 5,956.86 as of Mar. 2026, which is 2066% above its 10-year median of 275.07. GuruFocus rates AVR with a GF Score™ of 23/100. The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Anteris Technologies Global ranks better than 98.62% on this metric.

Anteris Technologies Global's average Accounts Payable for the three months ended in Mar. 2026 was $7.44 Mil. Anteris Technologies Global's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.11 Mil. Hence, Anteris Technologies Global's Days Payable for the three months ended in Mar. 2026 was 5,956.86.

The historical rank and industry rank for Anteris Technologies Global's Days Payable or its related term are showing as below:

AVR' s Days Payable Range Over the Past 10 Years
Min: 36.33   Med: 275.07   Max: 5447.1
Current: 4606.51

During the past 13 years, Anteris Technologies Global's highest Days Payable was 5447.10. The lowest was 36.33. And the median was 275.07.

AVR's Days Payable is ranked better than
98.62% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 67.87 vs AVR: 4606.51

Anteris Technologies Global's Days Payable increased from Mar. 2025 (2,505.63) to Mar. 2026 (5,956.86). It may suggest that Anteris Technologies Global delayed paying its suppliers.


Anteris Technologies Global Days Payable Historical Data

* Premium members only.

The historical data trend for Anteris Technologies Global's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anteris Technologies Global Days Payable Chart

Anteris Technologies Global Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 430.85 536.26 816.88 1,145.04 5,447.10

Anteris Technologies Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,505.63 3,353.13 3,588.42 7,706.11 5,956.86

AVR vs INMD, QDEL, SSII: Days Payable Comparison

For the Medical Devices subindustry, Anteris Technologies Global's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies Global Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Days Payable distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Days Payable falls into.


AVR
23GF Score
Anteris Technologies Global Corp AVR
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anteris Technologies Global Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Anteris Technologies Global's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (5.889 + 11.094) / 2 ) / 0.569*365
=8.4915 / 0.569*365
=5,447.10

Anteris Technologies Global's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (11.094 + 3.79) / 2 ) / 0.114*365 / 4
=7.442 / 0.114*365 / 4
=5,956.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 5,956.86 mean?
Anteris Technologies Global (AVR) has a Days Payable of 5,956.86 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Anteris Technologies Global and its competitors. This is 2066% above median its historical median of 275.07. Over the past decade, Anteris Technologies Global's Days Payable has ranged from 36.33 to 5,447.10. According to the industry distribution chart, Anteris Technologies Global ranks #11 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 1.4%.
Is Anteris Technologies Global's Days Payable too high?
Anteris Technologies Global's current Days Payable of 5,956.86 is 2066% above median its 10-year median of 275.07. Over the past 10 years, this metric has ranged from a low of 36.33 to a high of 5,447.10. The Medical Devices & Instruments industry median Days Payable is 67.87. Anteris Technologies Global's value of 5,956.86 is 8676.9% above this industry median. Based on the distribution chart, Anteris Technologies Global ranks #11 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Anteris Technologies Global has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's Days Payable compare to INMD and QDEL?
According to the Medical Devices & Instruments industry distribution chart, Anteris Technologies Global ranks #11 out of 795 companies for Days Payable. This places Anteris Technologies Global in the top 1% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Anteris Technologies Global's value of 5,956.86 is 8676.9% above this benchmark. Historically, Anteris Technologies Global's own Days Payable has ranged from 36.33 to 5,447.10 over the past decade. While the company's 10-year median is 275.07 vs. the industry median of 67.87, Anteris Technologies Global has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anteris Technologies Global's current Days Payable of 5,956.86 is 8676.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Anteris Technologies Global and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anteris Technologies Global's current Days Payable is 5,956.86, which is 2066% above median its own 10-year median of 275.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (AVR) has a current Days Payable of 5,956.86. The current Days Payable is 5,956.86, which is 2066% above median its 10-year median of 275.07 and 8676.9% above the Medical Devices & Instruments industry median of 67.87. Anteris Technologies Global's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Anteris Technologies Global (AVR), the current Days Payable is 5,956.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anteris Technologies Global Business Description

Other Exchanges AVR:Australia
Address 9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
23GF Score

Get the complete analysis for AVR

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.87
Price